(Q38899472)

7 September 2017

1 reference

title

Cutaneous leishmaniasis: immune responses in protection and pathogenesis (English)

1 reference

7 September 2017

0 references

cutaneous leishmaniasis

1 reference

Phillip Scott

1

1 reference

7 September 2017

Fernanda O Novais

series ordinal

2

1 reference

7 September 2017

publication date

18 July 2016

1 reference

Nature Reviews Immunology

7 September 2017

published in

1 reference

7 September 2017

volume

16

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

581-592

1 reference

Leishmaniasis worldwide and global estimates of its incidence

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmaniasis: complexity at the host-pathogen interface.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Lundep, a sand fly salivary endonuclease increases Leishmania parasite survival in neutrophils and inhibits XIIa contact activation in human plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Neutrophils and Macrophages Cooperate in Host Resistance against Leishmania braziliensis Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A blast from the past: clearance of apoptotic cells regulates immune responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Apoptotic cell clearance of Leishmania major-infected neutrophils by dendritic cells inhibits CD8⁺ T-cell priming in vitro by Mer tyrosine kinase-dependent signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A hypomorphic mutation in the Gfi1 transcriptional repressor results in a novel form of neutropenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Migratory dermal dendritic cells act as rapid sensors of protozoan parasites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Collective nitric oxide production provides tissue-wide immunity during Leishmania infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Altered immune responses in mice lacking inducible nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Recombinant interleukin 12 cures mice infected with Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Natural killer cell behavior in lymph nodes revealed by static and real-time imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A dynamic map of antigen recognition by CD4 T cells at the site of Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD4+ T Cells Rely on a Cytokine Gradient to Control Intracellular Pathogens beyond Sites of Antigen Presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

The early generation of a heterogeneous CD4+ T cell response to Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Tissue-resident memory T cells: local specialists in immune defence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

LR1: a candidate RNA virus of Leishmania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Severity of tegumentary leishmaniasis is not exclusively associated with Leishmania RNA virus 1 infection in Brazil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

The role of IL-10 in promoting disease progression in leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A role for IgG immune complexes during infection with the intracellular pathogen Leishmania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Modulation of dendritic cell function by Leishmania parasites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Arginase I, Polyamine, and Prostaglandin E2Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous Leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Interleukin 17 production among patients with American cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Disease severity in patients infected with Leishmania mexicana relates to IL-1β.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Interleukin-18 enhances a Th2 biased response and susceptibility to Leishmania mexicana in BALB/c mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRI.2016.72

31 March 2020

12 December 2020

PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD4+CD25+T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Compartmentalized control of skin immunity by resident commensals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Vector transmission of leishmania abrogates vaccine-induced protective immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Molecular regulation of effector and memory T cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Vaccines for the leishmaniases: proposals for a research agenda

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

First generation leishmaniasis vaccines: a review of field efficacy trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Vaccine adjuvants: putting innate immunity to work

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Key roles of adjuvants in modern vaccines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania vaccine development: exploiting the host-vector-parasite interface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Analysis of T helper cell responses during infection with Leishmania amazonensis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.72

Immunological phenomena in leprosy and related diseases

31 March 2020

1 reference

12 December 2020

Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha

1 reference

12 December 2020

Alterations of the immune response associated with chronic experimental leishmaniasis

1 reference

12 December 2020

IL-4 induces a Th2 response in Leishmania major-infected mice

1 reference

12 December 2020

Leishmania RNA viruses in Leishmania of the Viannia subgenus

1 reference

12 December 2020

Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages

1 reference

12 December 2020

Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells

1 reference

12 December 2020

Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells

1 reference

12 December 2020

Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major

1 reference

12 December 2020

Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis

1 reference

12 December 2020

Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.

1 reference

12 December 2020

Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis

1 reference

12 December 2020

Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

1 reference

12 December 2020

Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2016.72

1 reference

7 September 2017

1 reference